SEC Form 4 · accession 0001127602-15-002532
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Officer — EVP & Chief Operating Officer
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 8:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 20, 2015 | M | 4,000 | $50.09 | A | 5,153 | D | |
| Common Stock | Jan 20, 2015 | S | 4,000 | $146.48 | D | 1,153 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $50.09 | Jan 20, 2015 | M | 4,000 | D | Sep 15, 2010 | Sep 15, 2019 | Common Stock | 4,000 | 17,458 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.